Robust Self-Assembled Monolayers for Improved Hemocompatibility

Information

  • Research Project
  • 7271061
  • ApplicationId
    7271061
  • Core Project Number
    R43HL087447
  • Full Project Number
    1R43HL087447-01A1
  • Serial Number
    87447
  • FOA Number
    PA-06-20
  • Sub Project Id
  • Project Start Date
    9/1/2007 - 16 years ago
  • Project End Date
    10/31/2009 - 14 years ago
  • Program Officer Name
    BALDWIN, TIM
  • Budget Start Date
    9/1/2007 - 16 years ago
  • Budget End Date
    10/31/2009 - 14 years ago
  • Fiscal Year
    2007
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/28/2007 - 16 years ago

Robust Self-Assembled Monolayers for Improved Hemocompatibility

[unreadable] DESCRIPTION (provided by applicant): Robust Self-Assembled Monolayers for Improved Hemocompatibility Principal Investigator: Brink, Damon Project Summary / Abstract Implantable blood-contacting medical devices such as left ventricular assist devices (VADs) pose thrombosis risks to patients. These risks are exacerbated in the small blood conduits of pediatric ventricular assist devices. While commercially available hemocompatible coatings do not yet provide fully inert surfaces that resist clot formation, recent research suggests that self-assembled monolayers (SAMs) of poly(ethylene glycol) (PEG) hold promise in this regard. Unfortunately, these coatings are only weakly bonded to the surface and desorption quickly degrades performance. The aim of this project is to form inert, covalently-bonded PEG monolayers that do not degrade and will extend the usable life of VADs and other implantable devices. This will be accomplished using a novel SAM deposition method based on supercritical carbon dioxide which produces robust monolayers having high graft density and outstanding uniformity. The coatings will be fully characterized using surface analysis methods. Protein adsorption and cellular adhesion will be probed using whole blood assays under controlled flow conditions. Robust Self-Assembled Monolayers for Improved Hemocompatibility Principal Investigator: Brink, Damon Project Narrative Risks of thrombosis formation are significant in ventricular assist devices - particularly in the small blood conduits of pediatric devices. This work seeks to advance the promising poly(ethylene glycol) (PEG) coatings by providing a covalent chemical bond to titanium and alumina substrates. Covalent bonding will enhance the durability of the PEG coatings in the presence of flow induced shear loads. The PEG will be linked with silane functional groups and form a highly uniform self-assembled monolayer (SAM) when deposited via a solution of supercritical carbon dioxide. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    232148
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:232148\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LAUNCHPOINT TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
    826728685
  • Organization City
    GOLETA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    93117
  • Organization District
    UNITED STATES